ImmunoGen Buy Hold or Sell Recommendation
| IMGNDelisted Stock | USD 18.20 0.81 4.26% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding ImmunoGen is 'Not Rated'. The recommendation algorithm takes into account all of ImmunoGen's available fundamental, technical, and predictive indicators you will find on this site.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. In addition, we conduct extensive research on individual companies such as ImmunoGen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards ImmunoGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
ImmunoGen |
Execute ImmunoGen Buy or Sell Advice
The ImmunoGen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ImmunoGen. Macroaxis does not own or have any residual interests in ImmunoGen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ImmunoGen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
ImmunoGen Trading Alerts and Improvement Suggestions
| ImmunoGen is not yet fully synchronised with the market data | |
| ImmunoGen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 287.61 M. Net Loss for the year was (73.52 M) with loss before overhead, payroll, taxes, and interest of (104.76 M). | |
| ImmunoGen currently holds about 373.87 M in cash with (197.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.69. | |
| Over 91.0% of the company shares are owned by institutional investors |
ImmunoGen current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ImmunoGen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ImmunoGen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
ImmunoGen Returns Distribution Density
The distribution of ImmunoGen's historical returns is an attempt to chart the uncertainty of ImmunoGen's future price movements. The chart of the probability distribution of ImmunoGen daily returns describes the distribution of returns around its average expected value. We use ImmunoGen price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ImmunoGen returns is essential to provide solid investment advice for ImmunoGen.
| Mean Return | 3.02 | Value At Risk | -4.16 | Potential Upside | 8.32 | Standard Deviation | 17.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ImmunoGen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by White Lauren of 19519 shares of ImmunoGen subject to Rule 16b-3 [view details]
ImmunoGen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ImmunoGen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ImmunoGen Buy or Sell Advice
When is the right time to buy or sell ImmunoGen? Buying financial instruments such as ImmunoGen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ImmunoGen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Social Domain Thematic Idea Now
Social Domain
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in ImmunoGen Stock
If you are still planning to invest in ImmunoGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoGen's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |